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reamble
atient-based teaching has been used since the earliest days
f medical education and continues to be used today for
ducating medical students, physicians, nurses, and other
edical personnel. Patient demonstrations have evolved
rom bedside teaching, to the surgical amphitheater, to
ecorded medical procedures, and finally to broadcast live
ase demonstrations. With current telecommunication ca-
abilities, it is possible to transmit medical procedures
orldwide in real-time. Because of their perceived educa-
ional benefit and in parallel with advances in transmission
echnology, the use of live case demonstrations at medical
eetings has grown to include adult and pediatric interven-
ional and electrophysiology procedures. Many feel live
roadcasts are an effective educational tool, especially for
ew technical procedures that cannot be learned by self-
tudy or didactic presentations. However, as live case trans-
issions have proliferated, issues have been raised about
patient safety, the ethics of live broadcasts, and their value as
an educational tool. Both interventional cardiology and
electrophysiology are rapidly evolving fields with changing
educational needs, and many of the cases transmitted focus
on newer therapies that have not been formally tested in
randomized trials. The repeated demonstration of untested
therapies has the potential to dilute their educational value
and lead physicians into believing the therapy is advanta-
geous in the absence of appropriately controlled clinical
trials. This educational approach may not be an appropriate
model for advancing patient care. Cases that feature unap-
proved new devices may be interpreted as more promotional
than educational. Live demonstrations of endoscopy, bron-
choscopy, and dental procedures are being done, but there are
no published guidelines from the related professional societies
(1–3). The American Association for Thoracic Surgery and the
Society of Thoracic Surgery has published a statement on live
broadcasts of thoracic and cardiovascular surgery (4). Broad-
casts to the general public were prohibited, recorded broad-
casts, either edited or unedited, were deemed preferable to live
surgery broadcasts and they recommended national and inter-
national cardiothoracic societies consider prohibiting live
broadcasts to large audiences at their annual meetings.
Because of the growth of live case transmissions and these
concerns, the Society for Cardiovascular Angiography and
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Live Case Demonstrations October 5, 2010:1267–82nterventions (SCAI), the American College of Cardiology
oundation (ACCF), the Heart Rhythm Society (HRS),
he European Society of Cardiology (ESC), the Sociedad
atinoamericana de Cardiologı´a Intervencionista (SOLACI),
nd the Asian-Pacific Society of Interventional Cardiology
APSIC) formed this writing committee to review live case
emonstrations. The writing committee included Jessica W.
erg, JD, MPH, Professor of Law and Bioethics, Case
estern Reserve University, who provided counsel on legal
nd ethical issues. Although not officially involved, the
ccreditation Council for Continuing Medical Education
ACCME) was consulted to ensure all policies and concerns
f the ACCME were considered and the Food and Drug
dministration (FDA) was used as a resource. Finally, to
ncorporate a patient perspective, the writing committee
ngaged Mended Hearts, Inc., a national non-profit orga-
ization that provides support to patients with heart disease
nd advocacy for patient related policies and legislation. In
eveloping this document, it was appropriate to involve
hysicians with considerable experience in live broadcasts so
hat their knowledge could be included. However, their inclu-
ion introduced possible bias and a conflict of interest, as these
ndividuals are regarded as proponents of live case demonstra-
ions. Therefore by intent, the writing committee also included
hysicians who had minimal or no past association with live
ase demonstrations. All writing committee members were
equired to disclose any real or potential relationship that could
e perceived as a conflict of interest (Appendix A).
The SCAI was the convening organization for this
ocument and thus provided the primary staff support. As
he convening organization, the policies and procedures of
he SCAI for document development and reporting rela-
ionships with industry (RWI) were used although each of
he participating organizations followed their own internal
rocesses for peer review. SCAI requires that all authors
isclose any affiliations they consider relevant and important
ith any organization that to the author’s knowledge has a
irect interest, particularly a financial interest, in the subject
atter or materials under consideration. Such affiliations
nclude, but are not limited to, employment by an industrial
oncern, ownership of stock, membership on a standing
dvisory counsel or committee, membership on the board of
irectors, or being publicly associated with a company or its
roducts. Other areas of real or perceived conflict of interest to
e reported include honoraria, consulting fees, grants or funds
rom such corporations or individuals representing such cor-
orations. The final version of the document was peer reviewed
y individuals selected by the sponsoring organizations, but
isclosure of RWI from the peer reviewers was not requested.
he History of Live Demonstration Cases
nterventional Cardiology
n response to this developing subspecialty, new educational
ethods were required to train the growing number of shysicians seeking these skills. This educational process
egan much like the early days of surgery, with pioneering
xperts traveling to learn from others and to teach practicing
hysicians (5). This educational process affected Dr. An-
reas Gruentzig, who performed the first percutaneous
ransluminal coronary angioplasty (PTCA) in 1977 (6).
ruentzig’s work received rapid worldwide acclaim and he
as soon inundated with training requests. The vast number
f requests could not be accommodated by individual onsite
utorials. Less than 1 year after his first PTCA, Gruentzig
ddressed this training dilemma by conducting the first live
ase demonstration course in Zurich, Switzerland. Over the
ext 2 years, hundreds of physicians including many future
eaders in interventional cardiology attended his live dem-
nstration courses and witnessed the successes, limitations,
nd complications of PTCA. Gruentzig’s concept was to
reate an “audience presence” in the catheterization labora-
ory, so those observing could see, hear, interact, and
xperience all aspects of the case as it was performed.
ruentzig developed not only a medical procedure, but he
lso transformed physician training by pioneering the live
ase demonstration that has now been embedded in inter-
entional physician education for more than 30 years.
In the 1980s, along with the growth of PTCA, live
emonstration courses became an integral part of continu-
ng medical education (CME) for interventional cardiolo-
ists. Indirectly, the educational value of these courses was
alidated by the many U.S. hospitals that required atten-
ance at such courses to obtain and maintain interventional
rivileges. In the 1990s, as interventional cardiology grew,
o did the size of live demonstration courses. Audience
esponse systems augmented the participants’ educational
xperience, and moderated panel discussions during live
roadcasts stimulated educational discussion. Now, inter-
entional cardiology has broadened to include treatments
or structural heart disease and peripheral vascular disease.
his evolution has brought pediatric and adult interven-
ional cardiologists closer together and has increased their
ollaboration with surgeons and radiologists in the cardiac
atheterization laboratory, leading to “thematic” live case
ourses blending experts across specialties. In many ways,
he growth of interventional therapeutics has been inter-
wined with live case physician training to disseminate
volving techniques and new procedures, for the purpose of
mproving operator skills and patient outcomes. For the past
everal years, there have been approximately 50 live case
ducational events per year worldwide, many of which have
een sponsored by national and international organizations.
lectrophysiology
ive case demonstrations are now a component of many
ajor electrophysiology meetings. The first live case at the
nnual scientific sessions of HRS occurred in 2000 for an
udience of over 1,000 electrophysiologists. Since then, live
ases have been a regular feature at the HRS annual
cientific sessions and HRS now produces internet broad-
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October 5, 2010:1267–82 Live Case Demonstrationsasts of live cases as part of their web-based educational
rograms. Live cases were also included in 10 different
nternational and domestic electrophysiology meetings co-
ponsored or endorsed by HRS in 2008. These cases
emonstrated device implantation techniques and complex
atheter-ablation procedures.
ediatric and Adult Structural Heart Disease
he Pediatric Interventional Cardiac Symposium (PICS) in
997 was the first large meeting where live cases were
erformed on children and adults with congenital heart
isease. Attendance at meetings with a focus on pediatric
nterventions has steadily grown, as have the number and
ocations of these meetings.
ationale, Benefits, and Risks of Live Cases
or Educational Purposes
ltimately, the justification for live broadcast case demon-
trations should be based on answers to three critical
uestions.
hat is the Educational Value of Live Case
emonstrations?
ducation for medical professionals is offered in many
ormats including written materials, lectures, and patient
ased demonstrations. Although some aspects of interven-
ional cardiology and electrophysiology can be acquired
rom reading or didactic teaching, critical aspects of proce-
ures are difficult to learn without direct observation,
xplanation and ultimately, “hands-on” experience. Even for
stablished procedures, seeing how other physicians manage
linical situations has educational value for experienced
hysicians and can help them gauge their performance.
here are several proposed benefits of broadcast case dem-
nstrations. First, they provide an opportunity for a large
udience to observe procedures with expert commentary,
hereby providing education to more individuals than could
e reached by experts traveling to centers where cases are
erformed. However, because case demonstrations represent
nly one component of the entire CME process, it is
ifficult to quantify their added value. No specific metrics
xist to assess the impact of live case courses on physician
kills or patient outcomes. Thus, opinions concerning the
ducational value of live demonstrations are subjective and
ay simply reflect the biases of various stakeholder groups.
here has been little research examining the educational
alue of live cases in interventional cardiology or electro-
hysiology. A single study published nearly 20 years ago
xamined live demonstrations of PTCA from the perspec-
ive of the operators performing the cases and those observ-
ng the cases, but those data may not be relevant today (7).
lthough no contemporary data have been published that
ssess the educational value of live case broadcasts, course
valuations received from physicians indicate that live case
emonstrations are a popular component of meetings. phese evaluations could be interpreted as validating their
ducational value, or alternatively be interpreted by critics as
eaning they are more entertainment than education.
econd, healthcare providers can obtain a better under-
tanding of the indications for complex procedures, which
ay help them explain the details, risks, and benefits to
uture patients as part of informed consent. Third, allied
ealth professionals who support physicians in the perfor-
ance of these procedures can benefit by observing proce-
ure planning and resource requirements. Fourth, viewing
he technical aspects of procedures and the related discus-
ions may help basic and clinical scientists, engineers and
nventors. Unmet needs can be identified, leading to inno-
ation in device development. Fifth, live case demonstra-
ions of unapproved devices currently being evaluated within
pproved research protocols can increase awareness of the
tudies among investigators and potential investigators, and
ay aid in the recruitment of subjects. Finally, the demon-
tration of newly approved devices or devices under inves-
igation provides physicians with insight into the future,
hus helping to integrate new therapies with existing strat-
gies to enhance clinical practice.
re There Alternatives to Live Case
emonstrations?
or teaching interventional and electrophysiology proce-
ures, pure didactic modalities cannot substitute for an
ctual demonstration of the procedure. Both live and edited
ideotaped formats can provide the educational value noted
bove and enhance the educational experience beyond
idactic teaching.
There are several potential advantages to the videotaped
ase format. Time sensitive scheduling and case duration
ssues are more manageable, thus creating less pressure for
perators and staff and reducing possible hazards created by
ime constraints. The videotaped case format permits inter-
uptions, which easily allows moderator/panel discussion
ithout changing the case flow. Ideally, a videotaped case is
resented such that it mimics real world decision-making
nd permits interaction between the moderators and audi-
nce. Properly edited cases can focus audience attention on
ritical teaching elements while omitting more time-
onsuming or routine portions of the procedure. For exam-
le, ablations to treat ventricular tachycardia can be time
onsuming, but an edited videotaped format allows critical
arts of the case to be viewed in a pre-specified time period,
hile ensuring key teaching points are not eliminated.
inally, videotaped cases reduce the burden of identifying
ppropriate cases for transmission on a particular date, as
ases can be prerecorded and subsequently broadcast.
Conversely, there are disadvantages of edited videotaped
ases as a surrogate for live case transmissions. One per-
eived disadvantage is that videotaped cases are necessarily
scripted” and could be edited to favor optimal case out-
omes or other subjective biases. These alterations may
rovide an unrealistic or inaccurate perception of procedural
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Live Case Demonstrations October 5, 2010:1267–82etails. Inadvertently, this same problem can occur with live
ases if the transmission is truncated to meet broadcast
chedules. If truncation occurs, efforts should be made to
eturn to the case or provide an update to the audience
egarding the outcome and difficulties encountered. Video-
aped cases do not allow real-time bi-directional communi-
ation with the operators, thus eliminating the element of
bserver “presence” in the procedure room and preventing
xposure to spontaneous problem solving and decision
aking, features that are a unique and valued educational
spect of live case transmissions. However, it is unlikely the
pontaneous problem solving in any one live case would
ddress more than a few of the many complex issues that
ight arise during a procedure. In some educational
ourses, hybrid demonstrations combining a moderator and
panel of experts with both live and videotaped portions are
n excellent option that has been used effectively for lengthy
lectrophysiology procedures and may be appropriate for
ome interventional procedures. Procedure simulation is
lso maturing as a modality to teach and evaluate procedure
kills.
Whether the case is broadcast live or videotaped for later
iewing, it is essential to use an experienced production
eam that is familiar with the necessary requirements and
estrictions imposed by the medical environment. Proper
reparations, high quality and reliable equipment and, in
ome cases, even rehearsals may be necessary to optimize
ransmissions and enhance the educational experience for
he audience.
hat Are the Risks and Benefits to Patients
articipating in Live Cases?
atient Risks
he utmost priority during any procedure, whether in
outine clinical care or as part of a demonstration course, is
atient safety and completion of a successful procedure.
herefore, it is critical to examine whether live case trans-
issions pose new or unacceptable risks to patients. Several
oncerns have been raised about surgical procedures that are
able I. Potential Concerns Related to Live Surgical Cases
Increased infection risk associated with individuals who are unfamiliar with
sterile technique and the placement of filming equipment in the procedure
room
Disruption of the operating theatre by audiovisual technicians and
equipment, which may interfere with treatment
Time delays to accommodate transmission schedules
Hurried procedures due to transmission time constraints
Performance of cases outside of regular working hours
Changes in case strategies to accommodate the educational process or pre-
specified case transmission schedules
Distractions to the site operators associated with maintaining a dialogue with
moderators or panelists, or as part of providing an educational experience
Exposing visiting operators to an unfamiliar clinical environment and patient
care team, without proper review of the planned case
dapted from Sade et al. (4).roadcast live for demonstration (4) (Table I). Some of ahese concerns are more relevant to live surgical than
nterventional or electrophysiology case transmissions. In-
ection risk is increased with an open surgical field versus
ercutaneous procedures. Moreover, the limited field-of-
iew intrinsic to a surgical site often requires specialized
eiling and/or head-mounted cameras with custom lighting,
hereas the signal from the imaging platforms used during
nterventional procedures (X-ray, ultrasound, etc.) can be
aptured directly from in-room monitors. Time constraints
ssociated with surgical procedures are more problematic, as
rolonged general anesthesia or cardiopulmonary bypass
ime may increase patient risk. Interventional and electro-
hysiology procedures frequently use local anesthesia and
onscious sedation, allowing easier adjustment of critical
imes without incurring undue patient risks. However, there
re other concerns unique to interventional and electrophys-
ology cases. For example, support personnel wishing to not
isrupt the live transmission could be less apt to inform the
perator of changes in vital signs during the procedure.
oreover, a possible increase in contrast agent use and x-ray
xposure to satisfy the live case broadcast deserves more
nvestigation. The interventional and electrophysiology case
nvironments are less rigid than operating rooms and allow
or easier interaction with the operators, but caution is still
ecessary to prevent this interaction from becoming exces-
ive and detrimental to the procedure. The environment for
visiting operator may also be less threatening in an
nterventional setting, because the equipment and clinical
urroundings are often more generic. Nevertheless, if com-
unication barriers are significant and adequate case prep-
ration is not enforced, guest operators may pose unneces-
ary risks. More serious risks may develop if the planned
ase strategy is altered without reason to satisfy the live case
equirements. This might include the unplanned use of
pecific devices or modifications of optimal patient care
ractices, resulting in delays in treatment or prolongation of
he procedure. If such changes occur and pose a hazard to a
atient or cause an adverse outcome, a formal review of the
ase by the institution where the case originated should
ccur after the broadcast.
Data on the outcomes of live case demonstrations are
imited to what is shown during the transmission and there
re no reports of 30-day mortality or morbidity. Over the
ast 20 years, the Transcatheter Cardiovascular Therapeu-
ics (TCT) conference has broadcast 928 live cases from 101
linical sites, both inside and outside the United States (8).
wo procedure-related deaths occurred, despite the fact
hat many of these cases were in high-risk patients or in
atients with complex anatomy. In one case, a distal
oronary guide wire perforation occurred at the end of a
omplex intervention on a patient receiving a glycoprotein
Ib/IIIa inhibitor. Attempts to place a covered stent were
nsuccessful, emergency surgery was performed and the
atient died of complications following surgery. The other
eath occurred shortly after placement of a percutaneous
ortic valve when the patient developed severe mitral regur-
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October 5, 2010:1267–82 Live Case Demonstrationsitation and profound pump failure. The mortality rate for
CT cases is 0.21% (95% CI, 0.03% to 0.88%) and this is
ell within acceptable standards for such procedures (9).
omplications from 186 carotid stent procedures performed
t three high-volume centers during 22 live educational
ourses between 2001 and 2008 were recently reported (10).
he combined primary endpoint of death, myocardial
nfarction, or minor/major strokes occurred in 3.2% of
atients, an incidence no different than that reported in
ajor clinical trials (11). Because data on clinical outcomes
uring and after live case transmissions are scarce and no
ong-term follow-up data exist, the writing committee
roposes a national and international registry of all live case
roadcasts be established. In this way, more information on
he safety and educational value of live case broadcasts could
e obtained (Appendix B). Information could be collected
uring or shortly after the live case, or by reviewing taped or
rchived cases following the meeting. An alternative would
e to task those responsible for quality assurance at each
ost institution to submit independent information on the
ases performed and outcomes. In addition, the option of a
re and post-case quiz to determine how well the educa-
ional goals were met by the live demonstration should be
onsidered. Ultimately, the institutional ethics and quality
ssurance committees at the facility where the case origi-
ates are the final internal monitors of the live case process
nd patient outcomes.
atient Benefits
he primary purpose of case demonstrations is for educa-
ion and to improve the knowledge of physicians, which
hould improve care and thereby help patients. Objective
vidence of direct patient benefits from participation in a
emonstration case does not exist. Certain features of the
ive case process deserve mention, but there is no evidence
hese features improve patient outcomes. First, patients for
ive cases are carefully screened and the planned treatment
trategy is often reviewed and performed by the most
xperienced operators at the transmission site. Having the
ost experienced operators perform case may improve the
utcome for the individual patient. However, their experi-
nce may not translate to the larger population of physicians
erforming this procedure and could potentially harm pa-
ients if physicians later attempt procedures beyond their
apabilities. Second, more than one expert operator usually
erforms live case procedures, to minimize distractions and
aximize the dual goals of optimal patient care and educa-
ional benefit. Third, some live cases are selected to dem-
nstrate a new technology or technique. Providing patients
ho participate in the case demonstration access to these
ew therapies may improve their clinical outcome, but
ccess to new therapies that might benefit a patient should
ot be contingent upon live case participation. Fourth,
isiting operators can benefit patients by virtue of their
pecial skills, but must be oriented to the different work
nvironment. Patients should be informed if a guest oper- stor will participate in their case, and they should under-
tand the status of the guest operator (i.e., temporary
ospital privileges and state licensure) and any implications
elated to malpractice insurance coverage. Finally, the mod-
rator and panelists can provide their aggregate knowledge
nd experience to the operator, which has the potential to
enefit the patient undergoing the demonstration proce-
ure. There have been anecdotal situations where the
oderator or panelists observe a nuance or use their
ollective experience to advise the operator about technique
r device selection. The potential downside, however, is that
uggestions derived from individual experiences can vary
rom panel to panel and result in conflicting comments that
ay distract the operator, thus shifting focus from the
atient to the panel. Although there may be some patient-
enefit related to the features cited above, it would be
nappropriate to emphasize any of these in an attempt to
onvince a patient to participate in a live case demonstration.
Benefits to a population of patients may result from the
issemination of educational information to practicing physi-
ians who, in turn, apply that knowledge to their own patients.
his benefit is limited to the use of approved devices to which
he practicing physician has access or an understanding of
evices under investigation, which may require referral of a
atient to another center. Improved physician training that
esults in better skills and judgment can benefit patient care
eyond the confines of any single transmitted case. In addition
o enhanced training, patient participants in live cases may
xperience societal rewards or altruism from assisting with the
dvancement of medical knowledge in the spirit of helping
hysicians and other patients.
atient Rights and Informed Consent for
ive Case Demonstrations
ny alteration of the physician-patient care process must be
arefully scrutinized to ensure that all aspects of patient
ights, preferences and confidentiality are protected. In
ddition to informed consent for the medical procedure, a
eparate informed consent for participation in the case
emonstration is necessary. This document, specific to the
ive case broadcast, should be generated by the site and
pproved by the local institutional review board, ethics
ommittee, or committee that approves consent documents
Appendix C). The patient must be informed of potential
isks and benefits of the live case demonstration and
nformed that some of the risks are unknown and benefits,
f any, unproven. Once the patient has agreed to the medical
rocedure, having someone other than the physician oper-
tor obtain consent for the live broadcast provides some
istance and may limit the patient’s feeling of obligation to
articipate. The additional participation of a third-party
atient advocate in this consent process may be appropriate.
s with other teaching procedures, patients must under-tand that the primary purpose of the live case demonstra-
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Live Case Demonstrations October 5, 2010:1267–82ion is physician education, rather than a direct therapeutic
enefit for them. The informed consent process should
ccur in a non-pressured environment with adequate time
or discussion. If a patient declines the live broadcast, no
ther part of their care or relationship with the physician
hould be affected. Patients should maintain the right to
erminate their participation in the broadcast at any time up
o and during the broadcast. Patient privacy regulations such
s the Health Insurance Portability and Accountability Act
n the United States, as well as local hospital policies, apply
o these activities. Document translation into the patient’s
ative language is required. Additional burdens relating to
rotection of patient rights and confidentiality apply to live
ase demonstrations. Presentation of the patient history
ust be devoid of specific patient references or identifiers,
nd facial anonymity should be preserved. Patients are never
ntroduced to the viewing audience and any durable product
f the case demonstration must remain unidentified.
A vital aspect of patient rights is preservation of the
hysician’s ethical code of conduct to always act in the best
nterest of the patient. Good judgment and standards of
thical conduct must not become blurred by the enthusiasm
r energy surrounding a live case transmission. Unfortu-
ately, there is variability among live demonstration courses
nd all possible protections are not uniformly applied.
oving forward, the integrity of these educational events
ill depend on following a robust code of conduct, ulti-
ately resulting in accreditation of live case broadcasts. The
riting committee proposes that each course have indepen-
ent live case monitors to assess adherence to the code of
onduct proposed in this document, and that their assess-
ents be reviewed as part of the overall course review. If
eviations in case conduct occur, a corrective action plan
hould be developed. Moreover, as part of the required
ourse assessment by the audience, specific questions should
e included to assess the appropriateness of the educational
oals for the case, objectivity of the operators, moderator
nd panelists, protection of patient rights and any conflicts
f interest that may have influenced patient care irrespective
f whether or not they were disclosed to the audience.
he Ethics of Broadcast Demonstrations
nd Conflicts of Interest
uestions about a variety of ethical issues surround live case
ransmissions. Several of these fall under the broad category
f “commercialism.” Critics have commented that live cases
re simply a public spectacle rather than good physician
ducation. Indeed, broadcasts of surgical, interventional and
ther medical procedures are available as webcasts and on
ublic video sharing websites and, in some settings, appear
o be for marketing purposes rather than for CME (12,13).
he broadcast of medical procedures can have educational
alue for the public and raise awareness of important health
ssues. However, there should be no tolerance for overt or aovert commercial involvement or nonprofessional behavior
n broadcast demonstrations that distort the pure educa-
ional mission. Understandably, the broadcast format may
eature charismatic physician educators and the real time
spect does create a sense of drama. Nevertheless, all
ndividuals involved must conform to the highest standards
f ethical conduct and professional demeanor. In the United
tates, live cases should occur within the framework of a
ME meeting, thereby minimizing potential conflicts of
nterest and fostering a balanced presentation.
Live case broadcasts may place ethical codes of conduct in
onflict with the goals of physician education and training.
ven the most prepared and thoughtful operator cannot
ssure patients with complete certainty that there are no
dded risks associated with broadcast demonstrations. To
ulfill the physician’s ethical code of conduct, there must be
reasonable assurance that the demonstration case format
tself adds minimal risk of harm to the patient. A benefit-
o-harm assessment should be a requisite component of
hysician participation in all educational activities involving
atients to maintain the highest ethical standards. Partici-
ating patients should have no expectation of direct benefit.
onflicts of Interest and the Performance
f Live Cases
conflict of interest exists in any situation in which an
ndividual or business is in a position to exploit a profes-
ional or official activity for personal or commercial benefit.
conflict of interest can exist even if no improper act results
rom it, as it can create an appearance of impropriety that
an undermine confidence in the conflicted individual or
rganization. Over the past 10 years, there has been increas-
ng scrutiny of relationships between physicians or institu-
ions and industry. Many documents and codes of conduct
ave been developed by professional organizations, govern-
ent agencies and industry to provide guidance (14–25).
otential conflicts of interest related to live case demonstra-
ions are problematic because of the possibility that profes-
ional judgment about patient welfare could be clouded by
he opportunity for economic or other personal gain during
he live case demonstration. Institutions acting as the host
or live cases may also be subjected to these same conflict
ssues. Some potential conflicts are more easily recognized
han others, but all must be addressed to the extent feasible.
A conflict of interest exists if the physician has a financial
nterest in a product being demonstrated or other financial
elationships with an industry sponsor (26). Although the
hysician in question may be the best individual to demon-
trate the device, financial relationships must be clearly
isclosed to the audience and the patient before the case
emonstration. One mechanism to manage disclosure
ould require all potential conflicts to be reported to an
ndependent committee that determines whether the con-
ict of interest should be mitigated through other safe-
uards. Physicians performing live case demonstrations may
lso gain enhanced personal prestige and possibly increased
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October 5, 2010:1267–82 Live Case Demonstrationsatient referrals. Presumably, physicians chosen for live case
emonstrations are selected because of their expertise and
eaching skills. Live case demonstrations should not have
arketing intent or be perceived as a “commercial” for a
articular physician or their home institution. Although it is
ppropriate to acknowledge support from the host facility at
he beginning of the case, elaborate introductions meant to
ighlight the host facility are inappropriate. Excessive
randing of the host facility or a commercial sponsor by
ogos placed in the viewing field or branded attire is
nappropriate. Any financial arrangements between the
ME provider, the production company for live cases, the
perating physicians, and the host institution must be
learly disclosed. The present practice of briefing showing a
lide listing conflicts at the start of a presentation is
nadequate for a full understanding of the audience. There
re legitimate additional expenses incurred by facilities that
upport live cases, and reimbursement for these expenses is
ppropriate; however physicians and institutions should not
rofit financially from their participation in live cases. The
roduction and transmission of live demonstration cases is
xpensive and may not be supported by attendee registration
ees alone. Accordingly, the cost of many professional
edical meetings is heavily underwritten by industry fund-
ng through indirect educational grants (20,23). Pharma-
eutical and medical device companies develop new thera-
ies that benefit millions of patients, but it must be
ecognized that these companies have a responsibility to
heir stockholders who expect positive financial returns on
heir investments. The relationship between live case trans-
issions and industry funding of educational symposia can
ose a conflict of interest. Device and drug manufacturers
an potentially benefit from the mention of their products
uring live case demonstrations. However, it is contrary to
CCME regulations for the organizers of a meeting to
ccept money from industry earmarked for any particular
ctivity within the meeting (17). ACCME standards for
ommercial support require that any contributions from
ndustry be given in an unrestricted manner to the organi-
ation sponsoring a meeting, and that a separate program
ommittee determines the scientific content and format of
he meeting (17,20,22). A program committee should have
he sole authority to select the program topics, speakers,
emonstration cases, as well as case operators, moderators
nd panelists, and the committee should be blinded to the
ndustry sponsors and the amount provided. If possible, the
rogram should be finalized by the organizing committee in
dvance of requests for commercial support, to avoid even
he potential for conflict. To the extent possible, those
nvolved with live cases should mention products in a
eneric fashion (e.g., a coronary guidewire, angioplasty
alloon or ablation catheter) without the brand name
ssigned by a manufacturer. Statements by physicians indi-
ating that this product is their favorite for a particular
urpose must be avoided, because such statements can be
nterpreted as a product endorsement. Likewise, panel bembers and the moderator of the live case demonstration
hould refrain from asking questions that require the iden-
ification of specific brand name products. However, in
ertain situations only one specific product made by one
ompany will work, whereas other products in the same
eneral class are unsuitable. For physician education, men-
ion of the vendor and brand name of this unique product is
ppropriate with an explanation of why use of this specific
roduct is necessary. Efforts to identify companies and
roducts by camera angles clearly intended to show names
r logos are inappropriate. There is no obvious reason for
epresentatives of a company to have involvement in a live
ase demonstration. Before performing a live case demon-
tration, the operators should have enough experience with
he equipment used that additional technical support from
ompany representatives is unnecessary. Understanding the
esire to have everything go well during the transmission, it
s understandable to have technical support personnel on
tandby to assist if an equipment malfunction occurs, but
hey should have no active role in the procedure.
One of the most challenging issues is when a new product
s being developed and showcased in a live case being
ransmitted in the United States, to create interest before
DA approval and general commercial release. Consulta-
ion with the FDA is required to ensure that appropriate
ontrols are in place. After making a substantial investment
n the development of a product, companies are interested in
reating an immediate demand for it. In this circumstance,
he desire to provide funding for a live case demonstration
eaturing their product is understandable. However, such
argeted funding is specifically prohibited by the ACCME
17). Finally, multiple stakeholders can have conflicts of
nterest rooted in the desire to have a meeting be financially
uccessful. Success requires good attendance, which may be
nversely related to the amount of the registration fee and
irectly associated with funding from industry. Featured
romotion of live cases in mailings and electronic media
bout the meeting content has inherent marketing intent to
ncrease meeting attendance, which in turn benefits the
eeting organizers and industry sponsors.
pecial Considerations and Device Use in
ive Case Demonstrations
rocedure, Patient, and Operator Selection
ppropriate case selection for a live transmission is crucial
or the educational value of the broadcast and for preserving
atient safety. Two trends should be noted in live interven-
ional cases. First, there has been an emphasis on showing
tart-to-finish live cases to mimic the real-world situation
ather than selected portions. For long procedures, this can
e accomplished with a combination of videotaped and live
ortions, taking care that key steps are not excluded. There
ay be an occasional role for shortened live case vignettes,ut only when the educational objective is designed to
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Live Case Demonstrations October 5, 2010:1267–82emonstrate an isolated technique and not the complete
ase. Second, many courses or segments within courses now
eature specific themes developed around procedure types,
atient characteristics or devices. Clustering content the-
atically helps case operator and discussant selection, and
an focus the educational experience for the audience. Other
spects of live case and patient selection are shown in Table II.
The ideal characteristics for live case operators include
echnical expertise, an ability to educate, and calmness
nder stress. An operator may not possess all of these
ttributes, thus it has become common to enlist operator
eams to meet these characteristics. This approach empha-
izes the division of activities, such that one operator can
ocus on the procedure, while another operator responds to
ialogue from the moderator and discussants. This ap-
roach is important to prevent procedure times from be-
oming longer than those expected in a similar case under
outine clinical circumstances. Operators should not be
laced in situations where case complexity or required tasks
re unfamiliar, regardless of the moderator or discussant
ecommendations.
pecific Case and Device Situations
he live case environment mandates strict adherence to
any requirements. FDA-approved devices are permitted
or live case transmissions, but so-called off label use of these
evices requires further clarification. Many devices in stan-
ard clinical practice are used beyond the confines of labeled
ndications. As live case demonstrations should be relevant
o daily practice, off-label device use may be acceptable, but
ive case presentations should not be viewed as a forum to
ncourage off-label use. Promotion of off-label use can be a
isincentive for industry and investigators to complete the
linical studies needed to demonstrate a device’s safety and
able II. Goals for Case and Patient Selection for
ive Demonstrations
The rationale and indications for the procedure should be identified and
explained to the audience before starting the case. These should fit within
established guidelines or appropriate use criteria.
The case strategy should be reviewed in advance of the broadcast and reflect
the consensus of all available experts. Ideally, the case strategy should also
be reviewed in advance with the case moderators, so that teaching objectives
are understood.
The case should have well-defined teaching objectives that have a high
likelihood of being completed in the allotted time.
Cases should be of medium to high complexity such that the educational
lessons appeal to a broad audience with varying degrees of experience.
Very high-risk scenarios should be avoided, as there is a greater chance of
complications that may require the operators undistracted attention.
The demonstration of new devices or evolving treatment strategies may be
appropriate, but these procedures should be performed only by operators
with the greatest amount of experience with the new device.
Avoid non-standard techniques just for the sake of demonstrating a new
device or treatment strategy. Avoid undue emphasis on performing cases
simply to highlight a new device.
Avoid sensational or “oddity” cases which will have little educational value to
the practicing physician.ffectiveness for FDA approval. Off-label device use during aive cases should be identified for the audience and be
onfined to uses that are usually considered reasonable
tandard practice.
Medical devices that have not been approved by the FDA
nd are under clinical investigation cannot be used during
ive case transmissions broadcast from the United States
nless approved more than 30 days in advance by the FDA.
urrently, approval is on a case-by-case basis, through a
ormal process for each unapproved device and educational
vent. In some situations, the FDA has agreed that live case
xposure of a device undergoing clinical investigation might
timulate improved trial enrollment. In contrast, the FDA
as also declined to approve some requests, citing the
everity of the patient’s illness, device complexity, the
otential for increased patient risk, nearly complete clinical
rial enrollment, or inadequate time to review the submitted
ocumentation. Approval has been a difficult issue for cases
ransmitted from abroad, as there are different regulatory
odies in the host country and the FDA has no direct
urisdiction. However, regulatory requirements do exist in
any countries, some of which are relevant to case demon-
trations (27).
pecial Considerations for Pediatric and
dult Congenital Heart Disease Cases
s there are only a few devices approved by the FDA for use
n patients with congenital heart disease, the majority of
evices and catheters used for these interventions, whether
n daily practice or for live demonstration, are used “off-
abel” (28). No stents are currently approved for manage-
ent of branch pulmonary artery stenosis or coarctation of
he aorta and no balloon catheter has been approved for
ngioplasty in children. Furthermore, electrophysiologists
ack certain approved cardiovascular devices to treat heart
hythm disorders in pediatric patients. The paucity of
pproved devices for congenital heart disease treatment and
estrictions on the demonstration of devices under evalua-
ion is a dilemma for those wishing to educate physicians
reating these patients.
Because of smaller patient size and the complexity of their
natomy, performing interventions in pediatric patients
equires additional skills and live case demonstrations
hould only be done by physicians with considerable expe-
ience. Interventions in educational courses should be done
ith the goal of educating practicing interventional pediat-
ic cardiologists about the management of common cases
ather than rare and complex interventions that they may
ot encounter during their practice. Furthermore, infants
nd small children are at increased risk of hypothermia,
lood loss, radiation exposure and complications due to the
ntervention. Anesthesia support is recommended, espe-
ially in the very young. Delays in the performance of the
ase must be avoided to prevent heat loss, prolonged
nesthesia use and other complications. Demonstration
ases should be selected based on their educational value,
voiding very complex, rare, or time-consuming cases.
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October 5, 2010:1267–82 Live Case Demonstrationsccasionally, a hybrid approach with collaboration between
surgeon and the interventionalist or electrophysiologist
ay be the best option. Cases benefiting from this approach
hould be done in a hybrid laboratory that meets all
equirements of an operating room. However, the hybrid
nvironment mandates increased awareness of all of the
oncerns expressed about live surgical case demonstrations
4) (Table I). Using two experienced operators is essential,
ith one focused only on patient care. As many cases are
nique and there are few standard approaches, a dialogue
etween the operators, moderator, and panelists is especially
elpful, but is subject to the same concerns as noted for
dult cases. Because of the unique concerns regarding the
ediatric age group, live case demonstrations of high-risk
rocedures will rarely be justified.
During the discussion with the family and child about the
onduct of the live case, it is important to explain the
nvironment of the live case, potential hazards, and com-
lications. The consent form should outline all potential
isks of performing the procedure as a live demonstration.
or very young children, permission is obtained from the
arents. Verbal assent of children in addition to written
ermission of the parents is required as the child gains capacity,
nd full written consent may be appropriate from children
loser to the age of maturity. Children who have the capacity
o assent have the right to refuse filming of the procedure or
efuse to participate in any type of demonstration case.
anaging Live Case Complications
omplications may develop that must be managed imme-
iately. The opportunity to observe the real-time decision
rocess after adverse events provides a powerful learning
xperience. However, these are the very circumstances
here patient safety is most jeopardized and rapid reaction
s critical to the outcome. Several common sense rules apply
hen a complication occurs during a live broadcast, and
here should be a clear “chain-of-command” within the
rocedure team, production team and the moderator that is
stablished before the case. First and foremost, proper
anagement of complications takes priority over all educa-
ional objectives, and no aspect of the live case process
hould interfere with clinical care. Minor complications can
e managed during a continuous broadcast, as long as the
perators are comfortable that the necessary steps can be
aken and the moderator/panelist discussion is non-
ntrusive. For such complications, the judgment of case
perators and management suggestions from the moderator
r panelists can enhance the educational experience. How-
ver, at the first sign of clinical instability, it is best to
anage a life-threatening complication “off camera” with-
ut the stress of live case conditions and audience observa-
ion. The decision to terminate a live case transmission
hould come from the operator with collaboration from the
oderator, but the operator’s decision is always final.
ccasionally, interruption of the case can be temporary andt may be continued later, once clinical stability is re- tstablished. Whether the case remains “live,” identifying
hat went wrong, how to avoid a similar complication and
iscussing how to manage a complication is valuable edu-
ation for the audience. In the event of an important
omplication, a formal case review should be initiated by the
ost institution following the procedure.
oderator-Driven Panel Discussions
uring the evolution of live courses, there has been a
ransition from “operator-driven” to “moderator-driven”
iscussions. Initially, the most experienced physicians were
he operators themselves, and the bulk of teaching dialogue
as unidirectional from the operator to the audience. This
pproach placed the burden of both technical and educa-
ional content on the operator. Over time, emphasis has
hifted to the selection of an experienced moderator and a
ultidisciplinary panel of discussants, thus producing a
idirectional dialogue. As such, operators focus more on the
echnical aspects of the case while the moderator/panelists
acilitate educational discussions. The effectiveness of live
ase teaching can be diminished by excessive discussions,
hich can delay or interrupt optimal case flow. The ideal
oderator-driven live case presentation will have a comfort-
ble cadence, with the moderator directing questions and
omments to the site operators and modulating discussion
uch that case flow is maintained and patient safety is
reserved. The moderator must also assess presentation bias
nd conflicts of interest, protect patient confidentiality, and
ngage the expert panelists to be certain that different points
f view are expressed. Panelists should not disrupt the case
ow established by the moderator, should not speak simul-
aneously, and should await recognition by the moderator
efore interrupting the case flow. Finally, the moderator
hould reinforce the primary role of the case operators in
etermining case strategy, only interceding if key decision
oints have educational value. This more active and vital role of
he case moderator is essential to enhancing the educational
alue of live case transmissions, while also relieving excessive
urden on the case operators. The moderator and panelists
hould receive and acknowledge written instructions regarding
heir roles and conduct during a live case.
ontrols for the Internet Broadcast
f Case Demonstrations
ith improved internet broadband technologies, there has
een a proliferation of internet-based offerings utilizing live
ases. There are several potential advantages of such
nternet-based courses. Specifically, internet-based live cases
llow a larger and more international audience to partici-
ate. With the elimination of attendee travel costs, this
pproach may be a more cost effective way to educate
hysicians. By archiving the content, physicians are able to
iew the live case and panel discussion at more convenient
imes. Given the openness of the web, internet broadcasts
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Live Case Demonstrations October 5, 2010:1267–82ay allow physicians to see new technologies that may not
et be available in their country. Lastly, internet-based
ourses may enhance interaction among meeting partici-
able III. Code of Conduct for Live Case Demonstrations
atient Safety
1. Patient safety and completing a successful procedure are the highest prior
2. Performing the case as a “live or taped case demonstration” must not pose
3. Cases should be performed with a primary operator focused on the proced
moderator.
4. A pre-planned strategy for the case should be used and not altered except
5. Patients should be carefully screened before participation in live case dem
6. The planned treatment strategy should be reviewed and supervised by the
7. Visiting operators should be properly oriented to the laboratory before perfo
the daily operation of the laboratory. Patients should be informed if a gues
of the guest operator (i.e., temporary hospital privileges and state licensure
8. Serious complications should be managed “off-camera” so the operator’s o
9. Because of the unique concerns in the pediatric age group, live case demo
atient Privacy
1. Patients should not be identified and care is necessary to ensure their nam
important in the pediatric age group, as children may be especially sensitiv
2. Within the U.S., HIPAA regulations should always be enforced, but there are
addressed.
nformed Consent
1. The operating physician or a physician familiar with the procedure must inf
that will be performed. Separately, the risks and benefits of participation in
is for educational purposes and is not designed to provide direct benefit to
from participation in a live broadcast demonstration have not been studied
2. Once the patient has agreed to the medical procedure, having someone ot
distance and may limit the patient’s feeling of obligation to participate. The
may also be appropriate.
3. The patient must sign the standard informed consent document for the pro
potential risks/benefits of the live case format. These two consent process
4. Patients should understand that the purpose of the live case demonstratio
benefit they receive would be incidental.
5. The informed consent process should occur in a non-pressured environmen
should provide an explanation of the risks and benefit, a neutral third party
6. Patients may withdraw from live case participation at any time without pen
7. If a new device or therapy under investigation as part of an approved resea
receive the new therapy is not dependent on their participation in the live c
onflict of Interest
1. Educational meetings should have a conflict of interest oversight committe
participants or sponsors. All financial relationships between physicians par
committee. Any conflict of interest must be clearly disclosed to the audienc
2. Live case demonstrations should not be used as marketing or commercial
3. Excessive branding by the host facility or a commercial sponsor, for examp
and assistants is not permitted.
4. Financial arrangements between the CME provider, the physicians involved
committee.
5. Physicians performing live cases should mention products only in a generic
6. Panel members and the moderator of the live case demonstration should r
egulatory Considerations
1. Within the U.S., if a non-FDA approved device, drug or therapeutic strategy
2. Common off-label device use during live cases should be disclosed and not
case teaching activities.
ducational Imperatives
1. The specific educational goals of the case should always be noted for the a
2. Whenever possible, cases used for demonstration purposes should be base
which should be identified for the audience. Since guidelines and appropria
recommendations should also be identified.
3. At the conclusion of each case, the case moderator should provide a decla
4. Attendees of live case demonstrations should submit an assessment of the
demonstrations.
ME indicates continuing medical education; FDA, Food and Drug Administration; and HIPAA, Hants by means of real-time electronic communication, cncluding the possibility that attendees may be able to
nteract with other attendees in a real-time learning atmo-
phere. In addition to all of the recommendations for live
aningful additional risk to the patient.
d the patient, and a secondary operator to assist and interact with the case
nical necessities.
tions.
experienced operators at the transmission site.
any live demonstration cases, and should work with an operator familiar with
ator will participate in their case. The host institution should review the status
any implications related to malpractice insurance coverage.
cus is patient care.
ions of high-risk procedures are rarely justified.
ot inadvertently disclosed on display monitors. This confidentiality is especially
otential embarrassment.
privacy and confidentiality protections outside of HIPAA that must be
he patient of potential risks and possible benefits of the medical procedure
case demonstration should be discussed, emphasizing that the live broadcast
tient. Furthermore, the patient should be informed that the possible risks
ome may be unknown and the benefits, if any, are unknown.
an the physician operator obtain consent for the live broadcast provides some
tional participation of a third party patient advocate in the consent process
e and a specific site-generated informed consent document that explains the
uld be done separately.
ucational and is not designed to provide a direct therapeutic benefit. Any
adequate time for explanation and discussion. While the supervising physician
obtain the actual consent so the patient feels less obligated to participate.
otocol is used in a live case, the patient should understand that their ability to
posed of individuals with no relationship to the meeting organizers,
ing in live case presentations and industry must be clearly disclosed to this
the patient involved in the procedure.
tunities for either the physician or the host institution.
banners placed in the viewing field or branded attire worn by the physicians
he hosting institution should be fully disclosed to the conflict of interest
on if possible, unless clinically relevant.
from asking questions that require the identification of specific products.
ized for the case, specific approval from the FDA is required in advance.
the audience; unconventional off label use should be discouraged during live
ce before starting.
indications that match guidelines or appropriate use criteria recommendations,
criteria are not all-inclusive, cases performed outside of these
of the educational messages to the audience.
rience that is designed to determine the educational value of the live case
surance Portability and Accountability Act of 1996.ities.
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October 5, 2010:1267–82 Live Case Demonstrationsnique challenge related to content access. Given the
ossibilities for the promotion of new devices or procedures
o patients that may be taken out of proper context, and
ithout the background understanding of a true risk versus
enefit analysis, it is recommended that internet-based
roadcasts be restricted to healthcare providers and be
erformed in the setting of a CME course. Furthermore,
he use of a device under investigation could be interpreted
s commercial promotion of an unapproved product, which
s not permitted under the Code of Federal Regulations,
itle 21 CFR 812.7 (29). Internet broadcasts involving live
ases should not be used for promotion of a medical device
r drug, institution, or individual physician and external
inks to industry websites should not appear.
nternational Considerations
he practice of medicine and the delivery of healthcare vary
idely around the world. Regulatory processes and privacy
rotections like those in the United States are different in
any countries but do exist (27). There is less concern about
he performance of live case demonstrations in some coun-
ries and special consents may not be consistently used for
ive case demonstrations. Therefore, complete adoption of
he principles set forth in this statement in all countries may
e challenging, but should be considered to improve live
ase demonstration broadcasts.
ode of Conduct for Live Case
emonstrations
ased on the considerations in this document, a general
ode of conduct for live case demonstrations is T3 presented
n Table III. Further recommendations of the writing
ommittee are to establish an ongoing registry of live cases
o collect objective information for the purpose of better
nderstanding their educational value, assessing both acute
nd long-term patient outcomes, monitoring operator and
ourse behavior, and reviewing feedback from the audience
articipants.
onclusions
ive case demonstrations have evolved over the past 30 years
nd have become an integral and accepted part of education
or the practicing physician specializing in interventional
ardiology and electrophysiology. However, data examining
he educational value and patient risks of this teaching
ethod are sparse. Along with the proliferation of courses
nd the ability to broadcast such activities worldwide,
oncerns have been raised about the appropriateness of live
ase demonstrations, particularly regarding patient safety,
onflicts of interest, and the ethics of these events. After
valuating the pros and cons of live case demonstrations and
he available data, the writing committee cannot determine
1f the educational benefits of live case demonstrations
utweigh any potential negative consequences. It is not the
ntent of this statement to endorse or proscribe live case
emonstrations. Rather, it is the hope of this writing
ommittee that the principles set forth in this statement will
rovide guidance to those engaged in this activity, will help
o ensure patient safety and privacy, and will lead to the
ighest educational value possible. Professional organizations
hould consider adopting these recommendations for live case
emonstrations performed as part of meetings they promote.
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tructure
. Courses with live case broadcasts would be required to register the cases presented with a central registry.
. Funding for this registry would come from a modest fee paid by each course on a per case basis.
. In the U.S., participation in this registry would be a requirement for course approval by the ACCME.
ata Elements
. Educational goals of the case
a. Rationale for this case
i. Features new device
ii. Features new treatment strategy
iii. Anatomic theme (e.g., SVG treatment, bifurcation lesion)
iv. Clinical theme (e.g., diabetics, elderly)
b. Other
. Case demographic data
a. Site of case performance
b. Case operators
c. Moderator
d. Panelists
. In-hospital outcome
a. Mortality (Y/N)?
b. Complications (list specific)
c. One-month or longer follow-up
. Audience assessment
a. Any compromise in patient privacy observed (Y/N)?
i. Specify
b. Any compromise in patient safety (Y/N)?
i. Specify
c. Any conflict of interest observed (Y/N)?
d. Any inappropriate product branding or commercialism noted (Y/N)?
e. Did the operator(s) or discussants appropriately indicate that the devices used were:
1) investigational or approved; and
2) if approved whether device use was on or off-label?
f. Was this case useful in improving your knowledge/skills (Y/N)?
g. Was the behavior of the operator(s) appropriate and objective (Y/N)?
h. Was the behavior of the moderator appropriate (Y/N)?
i. Was the behavior of the panelists appropriate (Y/N)?
. Patient participant survey (completed following the live case)
a. Was the information provided as part of the informed consent to the live broadcast accurate (Y/N)?
b. Is there any other information you would have liked to be told about the live broadcast before participation? (Y/N)?
If yes, describe
c. Do you feel you received good care during the procedure (Y/N)?
d. Are you satisfied with your experience as a live case patient (Y/N)?
e. Would you do a live case again or advise a friend to do so (Y/N)?
f. Did you suffer any complications (Y/N)?
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he informed consent form for a live case demonstration should delineate the potential risks associated with the live case, such as
onger procedure times, starting delays due to transmission requirements and the potential for operator distraction. The document
hould include a statement that the live case is not designed to provide the patient with a direct therapeutic benefit but rather may
rovide educational benefit to physicians and subsequently to the patients they treat. Disclosure of the estimated size and
omposition of the audience and any conflicts of interest of the physicians or facilities involved should be included.
ample Consent Form for Live Case Demonstrations
onsent for Live Video Transmission of Procedure
Participation Duration: approximately ______ hours
....................................................................................................................................................................................................
Purpose:
You are being asked to allow you or your child’s ______________ [insert name of procedure here] to be either videotaped
nd/or shown in a live, real-time format to attendees in a medical education course. The name of this course is
______________________. The estimated number of individuals viewing your procedure will be ______ and the audience
ill be composed of physicians, other allied health professionals (nurses, technologists, etc.) and other individuals who may
e in the medical device or drug industry. This meeting is not open to the public and your procedure will not be shown to
he general public.
If you sign your name below, you agree to have your or your child’s medical procedure filmed and/or be shown live for
his purpose. In addition, it is possible that portions of your or your child’s procedure or the entire procedure will be shown
ater to medical professionals who could not attend the conference. In addition to the filming, your or your child’s medical
istory will be reviewed with the conference attendees so they understand why the procedure is being performed.
We will make every effort to not film or show your or your child’s face or disclose your or your child’s name in any way
uring the procedure. Should your or your child’s face or other identifying data be inadvertently included in the live
resentation, the subsequent video will be edited to remove such frames.
It is important that you or your child understand that you/he or she are not required to agree to this filming and there
re no penalties for refusal to participate. By agreeing to be filmed, you or your child permit your physicians the limited right
o only use the videotape of your procedure for educational and training purposes and to improve the quality of healthcare.*
*If a registry is developed, a separate consent form may be required and should provide relevant information as appropriate.
Risks:
In addition to the risks identified in the procedure consent form, additional risks of the filming may include:
X Prolonged procedure time
X Additional personnel present in the room where your procedure is performed
X Possible loss of privacy if identifying information is inadvertently disclosed
X Possible unknown risks, such as the distraction of the physician performing the procedure
Potential Benefits:
The primary benefit of the filming is for physician training and education. The filming is not designed to provide you or
our child with any direct therapeutic benefit.
Right to Withdraw:
You or your child may withdraw the consent at any time by notifying your physician. Your or your child’s care will not
e affected in any way if you or he/she withdraw consent for the filming or decline to participate.
Questions:
If you or your child have any questions please contact your physician. [Insert specific contact information here:]
o1282 Dehmer et al. JACC Vol. 56, No. 15, 2010
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I hereby consent to have my procedure filmed and/or shown live, and to be used in the future for the training or education
f physicians.
Name of Subject Signature Date & Time
Signature of Individual Obtaining Consent Date & Time
Signature of Witness Date & Time
Parent, Guardian or Legal Representative Signature Date & Time
